Ledger.

CEO, Prota Therapeutics

Professor Mimi Tang

Coverage

Stories naming Professor Mimi Tang. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

4 deals

Four Aussie startups that have raised $94.5 million already in January

Roundup of January 2024 funding: Futurerent, Prota Therapeutics, National Renewable Network and Getmee together secured $94.5 million across debt, equity and a government grant, with investor details for each deal.

Series A $32m

Allergies biotech startup Prota Therapeutics innoculated with $32 million in Series A1 raise

Prota Therapeutics, a Melbourne biotech, has secured $32 million in equity and debt ahead of a Phase 3 trial of its peanut allergy therapy, with Singapore's SPRIM Global Investments leading the round.

Also SmartCompany·SmartCompany·SmartCompany·Business News Australia·Forbes Australia

Something wrong? Tell us